Lorca, M.; Muscia, G.C.; Pérez-Benavente, S.; Bautista, J.M.; Acosta, A.; González, C.; Sabadini, G.; Mella, J.; Asís, S.E.; Mellado, M.
2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum: An In Silico Approach with Experimental Validation. Pharmaceuticals 2024, 17, 889.
https://doi.org/10.3390/ph17070889
AMA Style
Lorca M, Muscia GC, Pérez-Benavente S, Bautista JM, Acosta A, González C, Sabadini G, Mella J, Asís SE, Mellado M.
2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum: An In Silico Approach with Experimental Validation. Pharmaceuticals. 2024; 17(7):889.
https://doi.org/10.3390/ph17070889
Chicago/Turabian Style
Lorca, Marcos, Gisela C. Muscia, Susana Pérez-Benavente, José M. Bautista, Alison Acosta, Cesar González, Gianfranco Sabadini, Jaime Mella, Silvia E. Asís, and Marco Mellado.
2024. "2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum: An In Silico Approach with Experimental Validation" Pharmaceuticals 17, no. 7: 889.
https://doi.org/10.3390/ph17070889
APA Style
Lorca, M., Muscia, G. C., Pérez-Benavente, S., Bautista, J. M., Acosta, A., González, C., Sabadini, G., Mella, J., Asís, S. E., & Mellado, M.
(2024). 2D/3D-QSAR Model Development Based on a Quinoline Pharmacophoric Core for the Inhibition of Plasmodium falciparum: An In Silico Approach with Experimental Validation. Pharmaceuticals, 17(7), 889.
https://doi.org/10.3390/ph17070889
